These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

804 related items for PubMed ID: 32448163

  • 1. Pirfenidone alleviates pulmonary fibrosis in vitro and in vivo through regulating Wnt/GSK-3β/β-catenin and TGF-β1/Smad2/3 signaling pathways.
    Lv Q, Wang J, Xu C, Huang X, Ruan Z, Dai Y.
    Mol Med; 2020 May 24; 26(1):49. PubMed ID: 32448163
    [Abstract] [Full Text] [Related]

  • 2. Pirfenidone plays a biphasic role in inhibition of epithelial-mesenchymal transition in non-small cell lung cancer.
    Fujiwara A, Shintani Y, Funaki S, Kawamura T, Kimura T, Minami M, Okumura M.
    Lung Cancer; 2017 Apr 24; 106():8-16. PubMed ID: 28285699
    [Abstract] [Full Text] [Related]

  • 3. USP7 Promotes TGF-β1 Signaling by De-Ubiquitinating Smad2/Smad3 in Pulmonary Fibrosis.
    Tang F, Gong H, Ke T, Yang W, Yang Y, Liu Z.
    Discov Med; 2024 Aug 24; 36(187):1616-1626. PubMed ID: 39190377
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Exercise training ameliorates bleomycin-induced epithelial mesenchymal transition and lung fibrosis through restoration of H2 S synthesis.
    Du SF, Wang XL, Ye CL, He ZJ, Li DX, Du BR, Liu YJ, Zhu XY.
    Acta Physiol (Oxf); 2019 Feb 24; 225(2):e13177. PubMed ID: 30136377
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Bufotalin attenuates pulmonary fibrosis via inhibiting Akt/GSK-3β/β-catenin signaling pathway.
    Yin JZ, Li ZQ, Zhang XD, Wan ZJ, Qin HR, Yao LH, Li BL, Gao F, Yang YY.
    Eur J Pharmacol; 2024 Feb 05; 964():176293. PubMed ID: 38158113
    [Abstract] [Full Text] [Related]

  • 11. Suppression of SMOC2 reduces bleomycin (BLM)-induced pulmonary fibrosis by inhibition of TGF-β1/SMADs pathway.
    Luo L, Wang CC, Song XP, Wang HM, Zhou H, Sun Y, Wang XK, Hou S, Pei FY.
    Biomed Pharmacother; 2018 Sep 05; 105():841-847. PubMed ID: 30021376
    [Abstract] [Full Text] [Related]

  • 12. Respiratory exposure to nano-TiO2 induces pulmonary toxicity in mice involving reactive free radical-activated TGF-β/Smad/p38MAPK/Wnt pathways.
    Zhou Y, Ji J, Ji L, Wang L, Hong F.
    J Biomed Mater Res A; 2019 Nov 05; 107(11):2567-2575. PubMed ID: 31356723
    [Abstract] [Full Text] [Related]

  • 13. Urine-Derived Stem Cells Reverse Bleomycin‑Induced Experimental Pulmonary Fibrosis by Inhibition of the TGF-β1-Smad2/3 Pathway.
    Zhang Y, Xia Y, Zhang R, Zhou X, Jiang J.
    Cytotherapy; 2024 Oct 05; 26(10):1236-1244. PubMed ID: 38852093
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Tetraspanin 1 as a mediator of fibrosis inhibits EMT process and Smad2/3 and beta-catenin pathway in human pulmonary fibrosis.
    Liu G, Wang Y, Yang L, Zou B, Gao S, Song Z, Lin Z.
    J Cell Mol Med; 2019 May 05; 23(5):3583-3596. PubMed ID: 30869194
    [Abstract] [Full Text] [Related]

  • 16. Emodin ameliorates bleomycin-induced pulmonary fibrosis in rats by suppressing epithelial-mesenchymal transition and fibroblast activation.
    Guan R, Wang X, Zhao X, Song N, Zhu J, Wang J, Wang J, Xia C, Chen Y, Zhu D, Shen L.
    Sci Rep; 2016 Oct 24; 6():35696. PubMed ID: 27774992
    [Abstract] [Full Text] [Related]

  • 17. Pirfenidone Attenuates Renal Tubulointerstitial Fibrosis through Inhibiting miR-21.
    Bi L, Huang Y, Li J, Yang X, Hou G, Zhai P, Zhang Q, Alhaji AA, Yang Y, Liu B.
    Nephron; 2022 Oct 24; 146(1):110-120. PubMed ID: 34724669
    [Abstract] [Full Text] [Related]

  • 18. Cdc42-interacting protein 4 silencing relieves pulmonary fibrosis in STZ-induced diabetic mice via the Wnt/GSK-3β/β-catenin pathway.
    Zhang X, Liu Y, Shao R, Li W.
    Exp Cell Res; 2017 Oct 01; 359(1):284-290. PubMed ID: 28720386
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Novel RAS inhibitor 25-O-methylalisol F attenuates epithelial-to-mesenchymal transition and tubulo-interstitial fibrosis by selectively inhibiting TGF-β-mediated Smad3 phosphorylation.
    Chen H, Yang T, Wang MC, Chen DQ, Yang Y, Zhao YY.
    Phytomedicine; 2018 Mar 15; 42():207-218. PubMed ID: 29655688
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.